19 June 2013
Keywords: vion, fda, agree, spa, cancer, drug, trial
Article | 21 February 2005
USA-based Vion Pharmaceuticals says it has reached agreement with the US Food and Drug Administration on a Special Protocol Assessment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
18 June 2013
© 2013 thepharmaletter.com